img

Global Chagas Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chagas Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chagas Disease Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chagas Disease Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chagas Disease Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chagas Disease Drug key manufacturers include AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd, Eisai Co Ltd, GlaxoSmithKline Plc, Grupo Praxis Pharmaceutical SA, Humanigen Inc, Kancera AB and Merck & Co Inc, etc. AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd are top 3 players and held % sales share in total in 2022.
Chagas Disease Drug can be divided into Cz-007, Cz-008, D-121 and DNDI-0690, etc. Cz-007 is the mainstream product in the market, accounting for % sales share globally in 2022.
Chagas Disease Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Chagas Disease Drug industry development. In 2022, global % sales of Chagas Disease Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chagas Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca Plc
Bayer AG
Daiichi Sankyo Co Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
Grupo Praxis Pharmaceutical SA
Humanigen Inc
Kancera AB
Merck & Co Inc
Novartis AG
Oblita Therapeutics BVBA
Sanofi
Segment by Type
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chagas Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chagas Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chagas Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chagas Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chagas Disease Drug introduction, etc. Chagas Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Chagas Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Chagas Disease Drug Market Overview
1.1 Chagas Disease Drug Product Overview
1.2 Chagas Disease Drug Market Segment by Type
1.2.1 Cz-007
1.2.2 Cz-008
1.2.3 D-121
1.2.4 DNDI-0690
1.2.5 EPLBS-1246
1.2.6 EPLBS-967
1.2.7 Others
1.3 Global Chagas Disease Drug Market Size by Type
1.3.1 Global Chagas Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Chagas Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Chagas Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chagas Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Chagas Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Chagas Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Chagas Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Chagas Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Chagas Disease Drug Market Competition by Company
2.1 Global Top Players by Chagas Disease Drug Sales (2018-2024)
2.2 Global Top Players by Chagas Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Chagas Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Chagas Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chagas Disease Drug Market Competitive Situation and Trends
2.5.1 Chagas Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chagas Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Chagas Disease Drug Market
2.8 Key Manufacturers Chagas Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chagas Disease Drug Status and Outlook by Region
3.1 Global Chagas Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Chagas Disease Drug Historic Market Size by Region
3.2.1 Global Chagas Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Chagas Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Chagas Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Chagas Disease Drug Forecasted Market Size by Region
3.3.1 Global Chagas Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Chagas Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Chagas Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Chagas Disease Drug by Application
4.1 Chagas Disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Chagas Disease Drug Market Size by Application
4.2.1 Global Chagas Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Chagas Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Chagas Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chagas Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Chagas Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Chagas Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Chagas Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Chagas Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Chagas Disease Drug by Country
5.1 North America Chagas Disease Drug Historic Market Size by Country
5.1.1 North America Chagas Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Chagas Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Chagas Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Chagas Disease Drug Forecasted Market Size by Country
5.2.1 North America Chagas Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Chagas Disease Drug Sales in Value by Country (2024-2034)
6 Europe Chagas Disease Drug by Country
6.1 Europe Chagas Disease Drug Historic Market Size by Country
6.1.1 Europe Chagas Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Chagas Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Chagas Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Chagas Disease Drug Forecasted Market Size by Country
6.2.1 Europe Chagas Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Chagas Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Chagas Disease Drug by Region
7.1 Asia-Pacific Chagas Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Chagas Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Chagas Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Chagas Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Chagas Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Chagas Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Chagas Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Chagas Disease Drug by Country
8.1 Latin America Chagas Disease Drug Historic Market Size by Country
8.1.1 Latin America Chagas Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Chagas Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Chagas Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Chagas Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Chagas Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Chagas Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Chagas Disease Drug by Country
9.1 Middle East and Africa Chagas Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Chagas Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Chagas Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Chagas Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Chagas Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Chagas Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Chagas Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca Plc
10.1.1 AstraZeneca Plc Company Information
10.1.2 AstraZeneca Plc Introduction and Business Overview
10.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered
10.1.5 AstraZeneca Plc Recent Development
10.2 Bayer AG
10.2.1 Bayer AG Company Information
10.2.2 Bayer AG Introduction and Business Overview
10.2.3 Bayer AG Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer AG Chagas Disease Drug Products Offered
10.2.5 Bayer AG Recent Development
10.3 Daiichi Sankyo Co Ltd
10.3.1 Daiichi Sankyo Co Ltd Company Information
10.3.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
10.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products Offered
10.3.5 Daiichi Sankyo Co Ltd Recent Development
10.4 Eisai Co Ltd
10.4.1 Eisai Co Ltd Company Information
10.4.2 Eisai Co Ltd Introduction and Business Overview
10.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eisai Co Ltd Chagas Disease Drug Products Offered
10.4.5 Eisai Co Ltd Recent Development
10.5 GlaxoSmithKline Plc
10.5.1 GlaxoSmithKline Plc Company Information
10.5.2 GlaxoSmithKline Plc Introduction and Business Overview
10.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products Offered
10.5.5 GlaxoSmithKline Plc Recent Development
10.6 Grupo Praxis Pharmaceutical SA
10.6.1 Grupo Praxis Pharmaceutical SA Company Information
10.6.2 Grupo Praxis Pharmaceutical SA Introduction and Business Overview
10.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products Offered
10.6.5 Grupo Praxis Pharmaceutical SA Recent Development
10.7 Humanigen Inc
10.7.1 Humanigen Inc Company Information
10.7.2 Humanigen Inc Introduction and Business Overview
10.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Humanigen Inc Chagas Disease Drug Products Offered
10.7.5 Humanigen Inc Recent Development
10.8 Kancera AB
10.8.1 Kancera AB Company Information
10.8.2 Kancera AB Introduction and Business Overview
10.8.3 Kancera AB Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Kancera AB Chagas Disease Drug Products Offered
10.8.5 Kancera AB Recent Development
10.9 Merck & Co Inc
10.9.1 Merck & Co Inc Company Information
10.9.2 Merck & Co Inc Introduction and Business Overview
10.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Merck & Co Inc Chagas Disease Drug Products Offered
10.9.5 Merck & Co Inc Recent Development
10.10 Novartis AG
10.10.1 Novartis AG Company Information
10.10.2 Novartis AG Introduction and Business Overview
10.10.3 Novartis AG Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis AG Chagas Disease Drug Products Offered
10.10.5 Novartis AG Recent Development
10.11 Oblita Therapeutics BVBA
10.11.1 Oblita Therapeutics BVBA Company Information
10.11.2 Oblita Therapeutics BVBA Introduction and Business Overview
10.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Oblita Therapeutics BVBA Chagas Disease Drug Products Offered
10.11.5 Oblita Therapeutics BVBA Recent Development
10.12 Sanofi
10.12.1 Sanofi Company Information
10.12.2 Sanofi Introduction and Business Overview
10.12.3 Sanofi Chagas Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Sanofi Chagas Disease Drug Products Offered
10.12.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chagas Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chagas Disease Drug Industrial Chain Analysis
11.4 Chagas Disease Drug Market Dynamics
11.4.1 Chagas Disease Drug Industry Trends
11.4.2 Chagas Disease Drug Market Drivers
11.4.3 Chagas Disease Drug Market Challenges
11.4.4 Chagas Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chagas Disease Drug Distributors
12.3 Chagas Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cz-007
Table 2. Major Company of Cz-008
Table 3. Major Company of D-121
Table 4. Major Company of DNDI-0690
Table 5. Major Company of EPLBS-1246
Table 6. Major Company of EPLBS-967
Table 7. Major Company of Others
Table 8. Global Chagas Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Chagas Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 10. Global Chagas Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Chagas Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 12. Global Chagas Disease Drug Market Share in Value by Type (2018-2024)
Table 13. Global Chagas Disease Drug Price by Type (2018-2024) & (USD/Pcs)
Table 14. Global Chagas Disease Drug Sales by Type (2024-2034) & (K Pcs)
Table 15. Global Chagas Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Chagas Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Chagas Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 18. Global Chagas Disease Drug Price by Type (2024-2034) & (USD/Pcs)
Table 19. North America Chagas Disease Drug Sales by Type (2018-2024) & (K Pcs)
Table 20. North America Chagas Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Chagas Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Europe Chagas Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Chagas Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Asia-Pacific Chagas Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Chagas Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Latin America Chagas Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Chagas Disease Drug Sales (K Pcs) by Type (2018-2024)
Table 28. Middle East and Africa Chagas Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Chagas Disease Drug Sales by Company (2018-2024) & (K Pcs)
Table 30. Global Chagas Disease Drug Sales Share by Company (2018-2024)
Table 31. Global Chagas Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Chagas Disease Drug Revenue Share by Company (2018-2024)
Table 33. Global Market Chagas Disease Drug Price by Company (2018-2024) & (USD/Pcs)
Table 34. Global Chagas Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2022)
Table 37. Date of Key Manufacturers Enter into Chagas Disease Drug Market
Table 38. Key Manufacturers Chagas Disease Drug Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Chagas Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Chagas Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 42. Global Chagas Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Chagas Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Chagas Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 45. Global Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 46. Global Chagas Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 47. Global Chagas Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Chagas Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Chagas Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 50. Global Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 51. Global Chagas Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Chagas Disease Drug Sales by Application (2018-2024) & (K Pcs)
Table 53. Global Chagas Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Chagas Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 56. Global Chagas Disease Drug Price by Application (2018-2024) & (USD/Pcs)
Table 57. Global Chagas Disease Drug Sales by Application (2024-2034) & (K Pcs)
Table 58. Global Chagas Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Chagas Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Chagas Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 61. Global Chagas Disease Drug Price by Application (2024-2034) & (USD/Pcs)
Table 62. North America Chagas Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 63. North America Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Chagas Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Europe Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Chagas Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Asia-Pacific Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Chagas Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Latin America Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Chagas Disease Drug Sales by Application (2018-2024) (K Pcs)
Table 71. Middle East and Africa Chagas Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Chagas Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 73. North America Chagas Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Chagas Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Chagas Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 76. North America Chagas Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 77. North America Chagas Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Chagas Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Chagas Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Chagas Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 81. Europe Chagas Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Chagas Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Chagas Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Chagas Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 85. Europe Chagas Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Chagas Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Chagas Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Chagas Disease Drug Sales by Region (2018-2024) & (K Pcs)
Table 89. Asia-Pacific Chagas Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Chagas Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Chagas Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Chagas Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 93. Asia-Pacific Chagas Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Chagas Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Chagas Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Chagas Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 97. Latin America Chagas Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Chagas Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Chagas Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Chagas Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 101. Latin America Chagas Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Chagas Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Chagas Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Chagas Disease Drug Sales by Country (2018-2024) & (K Pcs)
Table 105. Middle East and Africa Chagas Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Chagas Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Chagas Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Chagas Disease Drug Sales by Country (2024-2034) & (K Pcs)
Table 109. Middle East and Africa Chagas Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Chagas Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Chagas Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 112. AstraZeneca Plc Company Information
Table 113. AstraZeneca Plc Introduction and Business Overview
Table 114. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. AstraZeneca Plc Chagas Disease Drug Product
Table 116. AstraZeneca Plc Recent Development
Table 117. Bayer AG Company Information
Table 118. Bayer AG Introduction and Business Overview
Table 119. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Bayer AG Chagas Disease Drug Product
Table 121. Bayer AG Recent Development
Table 122. Daiichi Sankyo Co Ltd Company Information
Table 123. Daiichi Sankyo Co Ltd Introduction and Business Overview
Table 124. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Daiichi Sankyo Co Ltd Chagas Disease Drug Product
Table 126. Daiichi Sankyo Co Ltd Recent Development
Table 127. Eisai Co Ltd Company Information
Table 128. Eisai Co Ltd Introduction and Business Overview
Table 129. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Eisai Co Ltd Chagas Disease Drug Product
Table 131. Eisai Co Ltd Recent Development
Table 132. GlaxoSmithKline Plc Company Information
Table 133. GlaxoSmithKline Plc Introduction and Business Overview
Table 134. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. GlaxoSmithKline Plc Chagas Disease Drug Product
Table 136. GlaxoSmithKline Plc Recent Development
Table 137. Grupo Praxis Pharmaceutical SA Company Information
Table 138. Grupo Praxis Pharmaceutical SA Introduction and Business Overview
Table 139. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product
Table 141. Grupo Praxis Pharmaceutical SA Recent Development
Table 142. Humanigen Inc Company Information
Table 143. Humanigen Inc Introduction and Business Overview
Table 144. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Humanigen Inc Chagas Disease Drug Product
Table 146. Humanigen Inc Recent Development
Table 147. Kancera AB Company Information
Table 148. Kancera AB Introduction and Business Overview
Table 149. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Kancera AB Chagas Disease Drug Product
Table 151. Kancera AB Recent Development
Table 152. Merck & Co Inc Company Information
Table 153. Merck & Co Inc Introduction and Business Overview
Table 154. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Merck & Co Inc Chagas Disease Drug Product
Table 156. Merck & Co Inc Recent Development
Table 157. Novartis AG Company Information
Table 158. Novartis AG Introduction and Business Overview
Table 159. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Novartis AG Chagas Disease Drug Product
Table 161. Novartis AG Recent Development
Table 162. Oblita Therapeutics BVBA Company Information
Table 163. Oblita Therapeutics BVBA Introduction and Business Overview
Table 164. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. Oblita Therapeutics BVBA Chagas Disease Drug Product
Table 166. Oblita Therapeutics BVBA Recent Development
Table 167. Sanofi Company Information
Table 168. Sanofi Introduction and Business Overview
Table 169. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Sanofi Chagas Disease Drug Product
Table 171. Sanofi Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Chagas Disease Drug Market Trends
Table 175. Chagas Disease Drug Market Drivers
Table 176. Chagas Disease Drug Market Challenges
Table 177. Chagas Disease Drug Market Restraints
Table 178. Chagas Disease Drug Distributors List
Table 179. Chagas Disease Drug Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Chagas Disease Drug Product Picture
Figure 2. Global Chagas Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Chagas Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Chagas Disease Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Cz-007
Figure 6. Global Cz-007 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Cz-008
Figure 8. Global Cz-008 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of D-121
Figure 10. Global D-121 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of DNDI-0690
Figure 12. Global DNDI-0690 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of EPLBS-1246
Figure 14. Global EPLBS-1246 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of EPLBS-967
Figure 16. Global EPLBS-967 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Global Chagas Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Chagas Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 21. North America Chagas Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. North America Chagas Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. Europe Chagas Disease Drug Sales Market Share in Volume by Type in 2022
Figure 24. Europe Chagas Disease Drug Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Chagas Disease Drug Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Chagas Disease Drug Sales Market Share in Value by Type in 2022
Figure 27. Latin America Chagas Disease Drug Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Chagas Disease Drug Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Chagas Disease Drug Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Chagas Disease Drug Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Chagas Disease Drug Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Chagas Disease Drug Revenue in 2022
Figure 33. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Hospital
Figure 35. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Clinic
Figure 37. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Chagas Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Chagas Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 42. North America Chagas Disease Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Chagas Disease Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Chagas Disease Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Chagas Disease Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Chagas Disease Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Chagas Disease Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Chagas Disease Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Chagas Disease Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Chagas Disease Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Chagas Disease Drug Manufacturing Cost Structure
Figure 53. Chagas Disease Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries